An unprecedented class of multichromic single crystals has been
investigated after their initial discovery almost 15~years ago in industry.
Single crystals have been prepared that are crystallographically identical, yet
may be grown colorless, yellow, or green from crystal to crystal, or
surprisingly, multicolored within the same crystal at all viewing angles, where
one would expect that only a single color would exist. The system examined
consisted of MeGaCl complexed with
1,4-bis(2,6-diisopropylphenyl)-1,4-diazabutadiene in varying ratios. The work
described is primarily geared towards understanding the factors leading to the
multichromic nature of the complexes. Our results indicate that the most
plausible explanation for the yellow/green mixed crystals is that the yellow
crystals are contaminated with small amounts of an intensely-colored blue
byproduct. In crystal regions where both the yellow and blue compounds are
found, the crystals appear dark green. Identification of the blue byproduct was
confirmed by X-ray diffraction.
We have found that addition of a 2:1 ratio of the bulky ligand Li[N(mesityl)(SiMe(3))] to SnCl(2) yields Sn[N(mesityl)(SiMe(3))](2), which is found by X-ray crystallography to be monomeric in the solid state. Interestingly, the solid state structure of the stannylene exhibits a "minipocket" caused by the parallel arrangement of the phenyl rings. A 1:1 ratio of ligand to SnCl(2) affords the new chlorotin amide [Sn(mu-Cl)[N(mesityl)(SiMe(3))]](3), which adopts a unique trimeric structure in the solid state. The chairlike (Sn-Cl)(3) backbone shown here has not been seen previously in Sn-halide chemistry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.